BeiGene

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BeiGene and other ETFs, options, and stocks.

About ONC

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. 

CEO
John V. Oyler
CEOJohn V. Oyler
Employees
11,000
Employees11,000
Headquarters
George Town, George Town
HeadquartersGeorge Town, George Town
Founded
2010
Founded2010
Employees
11,000
Employees11,000

ONC Key Statistics

Market cap
27.07B
Market cap27.07B
Price-Earnings ratio
-63.78
Price-Earnings ratio-63.78
Dividend yield
Dividend yield
Average volume
414.48K
Average volume414.48K
High today
$240.00
High today$240.00
Low today
$236.94
Low today$236.94
Open price
$238.46
Open price$238.46
Volume
39.23K
Volume39.23K
52 Week high
$287.88
52 Week high$287.88
52 Week low
$141.31
52 Week low$141.31

ONC News

Simply Wall St 6d
BeiGene (NasdaqGS:ONC) Reveals Promising Phase 1 Trial Results Across Multiple Cancer Studies

recently announced comprehensive analyses from clinical trials at EHA2025, focusing on hematological malignancies, reflecting its commitment to advancing treatm...

BeiGene (NasdaqGS:ONC) Reveals Promising Phase 1 Trial Results Across Multiple Cancer Studies
Simply Wall St 6d
Shareholders Would Not Be Objecting To BeiGene, Ltd.'s CEO Compensation And Here's Why

Key Insights BeiGene will host its Annual General Meeting on 21st of May CEO John Oyler's total compensation includes salary of US$1.10m Total compensation i...

Shareholders Would Not Be Objecting To BeiGene, Ltd.'s CEO Compensation And Here's Why

Analyst ratings

97%

of 36 ratings
Buy
97.2%
Hold
2.8%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.